Crystal S Langlais1, Rebecca E Graff2,3, Erin L Van Blarigan2,4, Nynikka R Palmer3,4,5, Samuel L Washington2,4, June M Chan2,3,4, Stacey A Kenfield2,3,4. 1. Department of Epidemiology & Biostatistics, University of California, San Francisco, 550 16th Street, San Francisco, CA, USA. crystal.langlais@ucsf.edu. 2. Department of Epidemiology & Biostatistics, University of California, San Francisco, 550 16th Street, San Francisco, CA, USA. 3. Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. 4. Department of Urology, University of California, San Francisco, San Francisco, CA, USA. 5. Department of Medicine, Division of General Internal Medicine at Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, USA.
Abstract
PURPOSE OF REVIEW: This study aimed to summarize evidence published between 1999 and June 2020 examining diet and lifestyle after prostate cancer (PC) diagnosis in relation to risk of biochemical recurrence, PC progression, and PC-specific mortality. RECENT FINDINGS: Secondary prevention is an important research area in cancer survivorship. A growing number of studies have reported associations between post-diagnostic modifiable behaviors and risk of PC outcomes. Evidence on modifiable lifestyle factors and PC remains limited. Where multiple studies exist, findings are often mixed. However, studies consistently suggest that smoking and consumption of whole milk/high-fat dairy are associated with higher risk of PC recurrence and mortality. In addition, physical activity and ½ to 1 glass of red wine/day have been associated with lower risk of recurrence and PC-specific mortality. Greater inclusion of racially/ethnically diverse groups in future research is necessary to understand these relationships in populations most impacted by adverse PC outcomes.
PURPOSE OF REVIEW: This study aimed to summarize evidence published between 1999 and June 2020 examining diet and lifestyle after prostate cancer (PC) diagnosis in relation to risk of biochemical recurrence, PC progression, and PC-specific mortality. RECENT FINDINGS: Secondary prevention is an important research area in cancer survivorship. A growing number of studies have reported associations between post-diagnostic modifiable behaviors and risk of PC outcomes. Evidence on modifiable lifestyle factors and PC remains limited. Where multiple studies exist, findings are often mixed. However, studies consistently suggest that smoking and consumption of whole milk/high-fat dairy are associated with higher risk of PC recurrence and mortality. In addition, physical activity and ½ to 1 glass of red wine/day have been associated with lower risk of recurrence and PC-specific mortality. Greater inclusion of racially/ethnically diverse groups in future research is necessary to understand these relationships in populations most impacted by adverse PC outcomes.
Authors: Sara S Strom; Ashish M Kamat; Stephen K Gruschkus; Yun Gu; Sijin Wen; Min Rex Cheung; Louis L Pisters; Andrew K Lee; Charles J Rosser; Deborah A Kuban Journal: Cancer Date: 2006-08-01 Impact factor: 6.860
Authors: James Y Dai; Bo Wang; Xiaoyu Wang; Anqi Cheng; Suzanne Kolb; Janet L Stanford; Jonathan L Wright Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-11-21 Impact factor: 4.254
Authors: Barbra A Dickerman; Thomas U Ahearn; Edward Giovannucci; Meir J Stampfer; Paul L Nguyen; Lorelei A Mucci; Kathryn M Wilson Journal: Int J Cancer Date: 2017-06-08 Impact factor: 7.396
Authors: A D Vandersluis; D E Guy; L H Klotz; N E Fleshner; A Kiss; C Parker; V Venkateswaran Journal: Prostate Cancer Prostatic Dis Date: 2016-06-28 Impact factor: 5.554
Authors: R Bruce Montgomery; Bryan Goldman; Catherine M Tangen; Maha Hussain; Daniel P Petrylak; Stephanie Page; Eric A Klein; E David Crawford Journal: J Urol Date: 2007-09-17 Impact factor: 7.450
Authors: Visalini Nair-Shalliker; Albert Bang; Sam Egger; Mark Clements; Robert A Gardiner; Anne Kricker; Markus J Seibel; Suzanne K Chambers; Michael G Kimlin; Bruce K Armstrong; David P Smith Journal: Sci Rep Date: 2020-05-08 Impact factor: 4.379
Authors: Crystal S Langlais; Rebecca E Graff; Erin L Van Blarigan; Stacey A Kenfield; John Neuhaus; Fred K Tabung; Janet E Cowan; Jeanette M Broering; Peter Carroll; June M Chan Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-09-02 Impact factor: 4.090
Authors: June M Chan; Stacey A Kenfield; Rebecca E Graff; Crystal S Langlais; Erin L Van Blarigan; Claire H Pernar; Meir J Stampfer; Edward L Giovannucci; Lorelei A Mucci Journal: Br J Cancer Date: 2022-08-26 Impact factor: 9.075
Authors: Crystal S Langlais; Yea-Hung Chen; Erin L Van Blarigan; Stacey A Kenfield; Elizabeth R Kessler; Kimi Daniel; Justin W Ramsdill; Tomasz M Beer; Rebecca E Graff; Kellie Paich; June M Chan; Kerri M Winters-Stone Journal: Integr Cancer Ther Date: 2022 Jan-Dec Impact factor: 3.077